Noted for its ‘outstanding performance’, the team at Baker McKenzie Krzyzowski i Wspólnicy Sp.k. is recommended for its vast knowledge of reimbursement issues and drug approval procedures. The group is also well-equipped to advise on distribution schemes. Praised by clients for providing ’superb service and unrivalled sectoral insights', practice head Juliusz Krzyżanowski is an expert in matters involving clinical trials, advertising, and investments into the healthcare space. Marcin Fiałka is adept at handling data privacy issues, with a strong focus on pharmaceutical market regulations and data processing work.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
'The Baker McKenzie Pharmaceutical team are not only regulatory experts with in-depth knowledge of pharmaceutical and reimbursement regulations. They are also excellent negotiators, and one can see their practical corporate background. They are familiar with market trends from the inside out. In this particular transaction everything was in a perfect setup and knew that we are in good hands.’
‘I work with Juliusz Krzyżanowski, who is trustworthy advisor with an objective view on the issues involved in a particular case. He always tries to fit our needs into legal possibilities. He is knowledgeable and has entire understanding of the business. Provides proposals to the point.’
Key clients
- 3M
- AbbVie
Work highlights
Advised Isba Gospodarcza on the legislative process regarding the amendment to the Polish Act on Reimbursement.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Juliusz Krzyżanowski
Other key lawyers
Marcin Fiałka